Skip to main content
Have a personal or library account? Click to login
Serum Interleukin Profile in Patients with Graves Orbithopathy Cover

Serum Interleukin Profile in Patients with Graves Orbithopathy

Acta Marisiensis - Seria Medica
Volume 59 (2013): Issue 1 (February 2013)
By: ,   and    
Open Access
|Aug 2013
References

References

  1. 1. Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh). 1989;120(4):473-8.
    Open DOISearch in Google Scholar
  2. 2. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(3):284-90.
    Open DOISearch in Google Scholar
  3. 3. Mohaseb K, Linder M, Rootman J, et al. Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroidassociated orbitopathy in graves' disease. Orbit. 2008;27(6):419-25.
    Open DOISearch in Google Scholar
  4. 4. Dickinson AJ, Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf). 2001;55(3):283-303.
    Open DOISearch in Google Scholar
  5. 5. Eckstein AK, Lösch C, Glowacka D, et al. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol. 2009;93(8):1052-6.
    Open DOISearch in Google Scholar
  6. 6. 6.Cozma I, Cozma LS, Boyce RL - Variation in thyroid status in patients with Graves' orbitopathy. Acta Endo (Buc). 2009;5(2):191-198.
    Open DOISearch in Google Scholar
  7. 7. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73(8):639-44.
    Open DOISearch in Google Scholar
  8. 8. Terwee CB, Prummel MF, Gerding MN, et al. Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathy. Clin Endocrinol (Oxf). 2005;62(2):145-55.
    Open DOISearch in Google Scholar
  9. 9. Prummel MF, Bakker A, Wiersinga WM, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol. 2003;148(5):491-5.
    Open DOISearch in Google Scholar
  10. 10. Dolman PJ. Evaluating Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):229-48.
    Open DOISearch in Google Scholar
  11. 11. Gerding MN, van der Meer JW, Broenink M, et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf). 2000;52(3):267-71.
    Open DOISearch in Google Scholar
  12. 12. Eckstein AK, Johnson KT, Thanos M, Esser J, Ludgate M. Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res. 2009;41(6):456-464.
    Open DOISearch in Google Scholar
  13. 13. Bellur SP, Bahn RS, Smith TJ. Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy. Endocrine Reviews. 2003;24(6):802-835.
    Open DOISearch in Google Scholar
  14. 14. Pappa A, Lawson JMM, Calder V, et al. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol. 2000;84:517-522.
    Open DOISearch in Google Scholar
  15. 15. Han R, Smith TJ. Induction by IL-1β of Tissue Inhibitor of Metalloproteinase-1 in Human Orbital Fibroblasts: Modulation of Gene Promoter Activity by IL-4 and IFN-γ. J. Immun. 2005;174(5):3072-3079.
    Search in Google Scholar
  16. 16. Cawood TJ, Moriarty P, O’Farrelly P, O’Shea D. The effects of tumour necrosis factor-α and interleukin1 on an in vitro model of thyroidassociated ophthalmopathy; contrasting effects on adipogenesis. Eur J Endocrinol. 2006;155:395-403.
    Open DOISearch in Google Scholar
  17. 17. Krassas GE, Wiersinga W. Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol. 2006;15:4777-78.
    Search in Google Scholar
  18. 18. Cawood TJ, Moriarty P, O’Farrelly P, O’Shea P. Smoking and Thyroid- Associated Ophthalmopathy: A Novel Explanation of the Biological Link. J Clin Endocrinol Metab. 2007;92:159-64.
    Open DOISearch in Google Scholar
  19. 19. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO Eur J Endocrinol. 2008;15:8273-285.
    Search in Google Scholar
  20. 20. Wakelkamp IMMJ, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients. Clin Endocrin. 2003;58(3):280-287.
    Search in Google Scholar
  21. 21. Szucs-Farkas Zs, Toth J, Kollar J, et al. Volume Changes in Intra- and Extraorbital Compartments in Patients with Graves' Ophthalmopathy: Effect of Smoking. Thyroid. 2005;15(2):146-151.
    Open DOISearch in Google Scholar
  22. 22. ThorntonJ, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye. 2007;21:1135-1145.
    Open DOISearch in Google Scholar
  23. 23. Wiersinga WM and Bartalena L. Epidemiology and Prevention of Graves' Ophthalmopathy. Thyroid. 2002;12(10):855-860.
    Open DOISearch in Google Scholar
  24. 24. de Carli M, D'Elios MM, Mariotti S, et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrin Metab. 1999;77:51120-1124.
    Search in Google Scholar
  25. 25. Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' Disease, and Thyroid-Associated Ophthalmopathy. Thyroid. 2008;18(9):953-95.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/amma-2013-0007 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 31 - 35
Published on: Aug 13, 2013
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Graves’ Orbitopathy,
interleukins,
smoking,
disease activity
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2013 Zsuzsánna Réti, Iz Kun, Corina Cristina Radu Pop, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons License.

Volume 59 (2013): Issue 1 (February 2013)
Previous article
Next article